Clinical Trial Update: Effects of Neoadjuvant Immunotherapy on Anti-tumour Immunity in Hepatocellular Carcinoma Patients Undergoing Liver Resection [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating neoadjuvant immunotherapy to enhance anti-tumor immunity in patients with hepatocellular carcinoma undergoing liver resection. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: University of Geneva, Switzerland | Conditions: Hepato Cellular Carcinoma (HCC), Immunotherapy | Phase 3 | Status: NOT_YET_RECRUITING